20
Euticals Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ADENOSINE, with a corresponding US DMF Number 22232.
Remarkably, this DMF maintains an Active status since its submission on November 25, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 21, 2013, and payment made on September 17, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II